Delivery Order SPE2DB20D3103-SPE2DB21FP9G0
Award Date
8/17/21
Potential Completion Date
8/18/21
Potential Value
$9.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $8,386.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a specialty pharmaceutical product. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,481.11 firm fixed price delivery order is for the supply of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a specialty pharmaceutical product. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a...
This federal contract award, valued at $93,128.18, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order for the pharmaceutical product GONAL-F RFF REDI-JECT 450 UNIT 0.75ML, with a performance period ending on May 14, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, to...
This federal contract award, valued at $16,286.10, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is for the delivery of GONAL-F RFF REDI-JECT 450 UNIT 0.75ML medical supplies, with a performance period through May 10, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract has no set-aside designation, indicating open competition....
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an award value of $1,097.52 and is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,781.72 firm fixed-price delivery order is for the supply of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a specialty medication. The contract has an ultimate completion date of January 20, 2022 and was awarded on January 19, 2022. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant...
This federal contract award, valued at $10,681.56, was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GONAL-F RFF REDI-JECT 450 UNIT 0.75ML, a medical product, with a completion date of November 8, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. AmerisourceBergen Drug Corp is the prime contractor and holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $15,594.00 firm fixed-price delivery order is for the supply of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a specialty medication. The award has an ultimate completion date of August 1, 2024. This contract is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,646.22 firm fixed-price delivery order is for the supply of GONAL-F RFF REDI-JECT 450 UNIT 0.75ML pharmaceutical product. The contract has a performance period through March 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award (SPE2DB20D3103|SPE2DB23FM6W2) was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,560,179,488 units of the drug GONAL-F RFF REDI-JECT 900. The contract, valued at $17,832.83, is a firm fixed-price delivery order with a completion date of March 8, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite...